<DOC>
	<DOCNO>NCT02389478</DOCNO>
	<brief_summary>The purpose study explore effect Oropharyngeal administration colostrum low birth weight infant sIgA lactoferrin , order explore protect immune function colostrum low birth weight infant , improve utilization breast milk reduce infection rate low birth weight infant .</brief_summary>
	<brief_title>Oropharyngeal Administration Colostrum Very Low Birth Weight Infants</brief_title>
	<detailed_description>The number low born weight infant increase every year.they suffer many questions.Recent study show Oropharyngeal administration colostrum low birth weight infant reduce time reach full enteral nutrition .But evidence support promote infant ' immune response . The hypothesis current study Oropharyngeal administration colostrum low birth weight infant may increase secretion sIgA urine saliva . The current study adopts randomize , double blind , control intervention trial , give Oropharyngeal administration colostrum low birth weight infant intervention group Oropharyngeal administration Normal saline control group . All indicator study discrete trait , sIgA、Lactoferrin number Saliva urine， number CRP，time Begin oral feeding，time full enteral feeding， Person 's chi-square test use comparison . For Blood culture results，The number necrotizing enterocolitis ( NEC ) occurred， investigator use Chi-square test comparison two group . The study expect Oropharyngeal administration colostrum low birth weight infant increase secretion sIgA urine saliva .</detailed_description>
	<mesh_term>Body Weight</mesh_term>
	<mesh_term>Birth Weight</mesh_term>
	<criteria>1 . Born weight≤1500g 2. transferred hospital within 24 hour birth 3. mother provide colostrum 4. parent infant agree participate study 1 . The infant suffer lifethreatening condition , severe heart disease , whose survival time expect &lt; 30d 2 . The infant suffer kind disease , impact take human milk mouth . ( gastrointestinal malformation , NEC , etc.） 3. human milk contraindicate An infant whose mother : Is infect human immunodeficiency virus ( HIV ) Is take antiretroviral medication Has untreated active tuberculosis Is infect human Tcell lymphotropic virus type l Is use dependent illicit drug except breastmilk medically indicate Is take prescribed cancer chemotherapy agent contraindicate breastfeeding Is receive medication contraindicate breast feeding Is receive diagnostic therapeutic radioactive isotope exposure radioactive material ( long radioactive milk ) An infant diagnose galactosemia , rare genetic metabolic disorder</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>1 Month</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>oropharyngeal</keyword>
	<keyword>breastmilk</keyword>
	<keyword>colostrum</keyword>
	<keyword>human milk</keyword>
	<keyword>premature infant</keyword>
</DOC>